Andrew Stewart Plump sold $2.1M of TAK stock

Andrew Stewart Plump, President, R&D of Takeda Pharmaceutical Co Ltd (TAK), sold 116,191 shares of TAK stock worth $2.1M, per an SEC Form 4 filed Sep 4, 2026.

The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.

The trade happened on Sep 2, 2026, 2 days before it was made public.

TAK has moved +14.5% since the trade date, from $18.43 to $21.09 (Nov 9, 2026 close).